Pulsenmore Ltd. PLSM

What this company does

The company currently has two primary products, the Pulsenmore ES and the Pulsenmore FC, and an additional third portable ultrasound solution in earlier developmental stages, the Pulsenmore MC. The Pulsenmore ES is a non-invasive home ultrasound device that is clinically proven to support prenatal care by allowing expectant mothers to perform self-scans and telehealth guided scans at home, and is approved for use in several key markets including the United States, Europe, Switzerland, Australia, Brazil, Colombia and Israel. The Pulsenmore FC is intended for self-examination of ovarian follicles and endometrial tissue in women undergoing in vitro fertilization (IVF) or fertility preservation, and is approved for use in Israel. Mobile ultrasound devices are a fast-growing category within the broader imaging diagnostics sector including X-ray, CT, MRI, PET and Ultrasounds. The company controls and monitors the quality of its products in its headquarters in Israel, where the final assembly and packaging of products is completed. As of March 15, 2026, the company had 63 employees in full-or part-time capacities, 51 of whom are located in Israel.

Written from the business description in Pulsenmore Ltd.'s annual report to the U.S. Securities and Exchange Commission, filed 30 March 2026. Every sentence was checked against that document before publication.